N,N'-diphenyl-1,4-phenylenediamine

N,N'-diphenyl-1,4-phenylenediamine: Overview.

Mechanism: Pharmacologically active on Apolipoprotein B-100
Curator reviewed
First approval: United States, 2012

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 10, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Marketed productAcross 1 country and 1 labeller

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with N,N'-diphenyl-1,4-phenylenediamine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.